Anthony Wong

3.7k total citations · 1 hit paper
62 papers, 2.6k citations indexed

About

Anthony Wong is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Anthony Wong has authored 62 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 14 papers in Surgery. Recurrent topics in Anthony Wong's work include Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Advanced Radiotherapy Techniques (9 papers). Anthony Wong is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Advanced Radiotherapy Techniques (9 papers). Anthony Wong collaborates with scholars based in United States, Canada and China. Anthony Wong's co-authors include Kartik Chandran, Sean P. J. Whelan, Nirupama Mulherkar, John M. Dye, Ana I. Kuehne, Thijn R. Brummelkamp, April M. Griffin, Gregor Obernosterer, Gordon Ruthel and Jan E. Carette and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Anthony Wong

55 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ebola virus entry requires the cholesterol transporter Niemann–Pick C1

2011 972 citations Jan E. Carette, Matthijs Raaben et al. Nature profile →

Peers

Anthony Wong

ONCOL

EPIDE

PRM

Brad R. Rosenberg United States

Thomas McKee Switzerland

Eric Stawiski United States

Don Morris Canada

Serena Bonin Italy

Chunxiao Xu United States

Aby Buchbinder United States

Michael Buckstein United States

Shyh‐Han Tan United States

Chen Zhao China

Brad R. Rosenberg United States

Anthony Wong

1.4k ×1.5

470 ×0.6

250 ×0.6

ONCOL

333 ×0.8

EPIDE

111 ×0.3

PRM

Citations per year, relative to Anthony Wong Anthony Wong (= 1×) peers Brad R. Rosenberg

Countries citing papers authored by Anthony Wong

Since Specialization

Citations

This map shows the geographic impact of Anthony Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Wong more than expected).

Fields of papers citing papers by Anthony Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Wong. The network helps show where Anthony Wong may publish in the future.

Co-authorship network of co-authors of Anthony Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Wong. A scholar is included among the top collaborators of Anthony Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Wong. Anthony Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Anthony, et al.. (2024). ControlMTR: Control-Guided Motion Transformer with Scene-Compliant Intention Points for Feasible Motion Prediction. 1507–1514. 4 indexed citations

Hoffman, Richard M., Paul L. Nguyen, Dana E. Rathkopf, et al.. (2024). Long-Term Patient-Reported Health-Related Quality of Life in the Randomized FORMULA-509 Trial of Salvage Radiotherapy and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate Plus Prednisone and Apalutamide after Radical Prostatectomy. International Journal of Radiation Oncology*Biology*Physics. 120(2). S54–S54.

Nguyen, Paul L., Marisa Kollmeier, Dana E. Rathkopf, et al.. (2023). FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP). International Journal of Radiation Oncology*Biology*Physics. 117(2). S81–S82. 1 indexed citations

Oh, David Y., Anthony Wong, Katsuto Shinohara, et al.. (2023). 862 TLR9 agonism promotes cytotoxic T cell persistence and myeloid remodeling when combined with radiation therapy and PD-1 blockade in oligometastatic prostate cancer patients. SHILAP Revista de lepidopterología. A961–A961. 1 indexed citations

Herlemann, Annika, Janet E. Cowan, Samuel L. Washington, et al.. (2023). Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. European Urology. 85(6). 565–573. 15 indexed citations

Chen, Katherine, et al.. (2023). Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy. Brachytherapy. 22(3). 304–309. 2 indexed citations

Wong, Anthony, et al.. (2023). Retail chain pharmacy opioid dispensing practices from 1997 to 2020: A content analysis of internal industry documents. SHILAP Revista de lepidopterología. 9. 100199–100199. 2 indexed citations

Chan, Jason W., et al.. (2022). Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost. Radiation Oncology. 17(1). 12–12. 5 indexed citations

Shee, Kevin, Albert J. Chang, Anthony Wong, et al.. (2022). Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial. Advances in Radiation Oncology. 7(5). 100941–100941. 5 indexed citations

10.

Greenland, Nancy, Matthew R. Cooperberg, Anthony Wong, et al.. (2021). Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer. Investigative and Clinical Urology. 63(1). 27–27. 10 indexed citations

11.

Wu, Susan, Anthony Wong, Katsuto Shinohara, et al.. (2021). Salvage High-Dose-Rate Brachytherapy for Recurrent Prostate Cancer After Definitive Radiation. Practical Radiation Oncology. 11(6). 515–526. 10 indexed citations

12.

Bortz, Robert H., Anthony Wong, Hannah S. Recht, et al.. (2020). A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition. Journal of Virology. 94(18). 8 indexed citations

13.

Golden, Daniel W., Anthony Wong, C. Stepaniak, et al.. (2016). A feasibility study of 2-mm bolus for postmastectomy radiation therapy. Practical Radiation Oncology. 7(3). 161–166. 12 indexed citations

14.

Zhang, Cathy C., Adam Pavlı́c̀ek, Qin Zhang, et al.. (2012). Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models. Clinical Cancer Research. 18(18). 5008–5019. 53 indexed citations

15.

Zhang, Cathy C., Zhengming Yan, Wenlin Li, et al.. (2011). [18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells. Clinical Cancer Research. 18(5). 1303–1312. 62 indexed citations

16.

Carette, Jan E., Matthijs Raaben, Anthony Wong, et al.. (2011). Ebola virus entry requires the cholesterol transporter Niemann–Pick C1. Nature. 477(7364). 340–343. 972 indexed citations breakdown →

17.

Zhang, Cathy C., Zhengming Yan, Qin Zhang, et al.. (2010). PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity. Clinical Cancer Research. 16(21). 5177–5188. 58 indexed citations

18.

Shojaei, Farbod, Joseph H. Lee, Brett H. Simmons, et al.. (2010). HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors. Cancer Research. 70(24). 10090–10100. 267 indexed citations

19.

Wei, Ping, Marlena Walls, Ming Qiu, et al.. (2010). Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design. Molecular Cancer Therapeutics. 9(6). 1618–1628. 158 indexed citations

20.

Zhang, Cathy, Zhengming Yan, Cory L. Painter, et al.. (2009). PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts. Clinical Cancer Research. 15(14). 4630–4640. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact